Articles

Siteman

Source: SITEMAN Cancer Center, Julia Evangelou Strait, June 2021.

biocentury-logo

Source: BIOCENTURY Wugen: deploying memory NK cells against cancer AND TURNING ALLOGENEIC CAR T CELLS AGAINST T CELL MALIGNANCIES BY LAUREN MARTZ, …

TN

Currently approved cellular therapies have been shown to effectively treat B-cell cancers, but there remains a significant unmet need for treating other cancers, including solid tumors.

bioworld
TN

Technology Networks, Ryan Sullivan, Wugen, March 2021

bizjournal

St. Louis Business Journal, Nathan Rubbelke, March 2021

bizjournal

St. Louis Business Journal, Nathan Rubbelke, February 2021

biospace

Latest News

Wugen’s proprietary platform employs a GMP-grade, feeder cell-free manufacturing process to produce commercially scalable, off-the-shelf, …

ST. LOUIS, MO and SAN DIEGO, CA, November 10, 2021 – Wugen, Inc., a clinical-stage …

ST. LOUIS, MO and SAN DIEGO, CA, November 9, 2021 – Wugen, Inc., a clinical-stage …

Next in our story